ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
Recruiting · NCT04891198 · Registry updated 2026-03-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 2 | 2026-03-25 | NCT04891198 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 3D Medicines (Sichuan) Co., Ltd. | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 85 |